Skip to main content

Rhenman & Partners Asset Management AB

Position in VKTX — Viking Therapeutics, Inc.

CIK 1599882 Stockholm, V7

Position in VKTX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$5,206,400
+$2,286,460 QoQ
Shares Held
160,000
+92.8% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Rhenman & Partners Asset Management AB holds $297,378,771 across 37 Biotechnology names. VKTX ranks #22 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,206,400 160,000
2025-12-31 $2,919,940 83,000
2025-09-30 $5,684,048 216,288
2025-06-30 $2,252,500 85,000
2025-03-31 $2,415,000 100,000
2024-12-31 $3,621,600 90,000
2024-09-30 $6,489,275 102,500
2024-06-30 $6,096,150 115,000
2024-03-31 $11,890,000 145,000
2023-12-31 $3,349,800 180,000
2023-09-30 $1,992,600 180,000
2023-06-30 $2,917,800 180,000
2023-03-31 $2,997,000 180,000
2020-03-31 $936,000 200,000